Drugs in MeSH Category Adjuvants, Immunologic
✉ Email this page to a colleague
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Pharma | ERGAMISOL | levamisole hydrochloride | TABLET;ORAL | 020035-001 | Jun 18, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sandoz | GLATOPA | glatiramer acetate | INJECTABLE;SUBCUTANEOUS | 206921-001 | Feb 12, 2018 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Synthon Pharms Inc | GLATIRAMER ACETATE | glatiramer acetate | INJECTABLE;SUBCUTANEOUS | 203857-001 | Sep 25, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sandoz | GLATOPA | glatiramer acetate | INJECTABLE;SUBCUTANEOUS | 090218-001 | Apr 16, 2015 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |